Back to search
FDAFDA · Food and drugs·Recall number D-0240-2015

Cyproheptadine HCl Syrup (Cyproheptadine HCl Oral Solution, USP) 4mg/10 mL, Rx ONLY, Pharmaceutical Associates, Inc., Greenville, SC 29605, NDC 0121-4788-10

Published November 12, 2014 · Recall initiated: October 16, 2014

Summary

FDA records drug Class II recall D-0240-2015, published November 12, 2014 and initiated October 16, 2014. Recalling firm: Pharmaceutical Associates Inc; Status: Terminated; Reported quantity: 9,640 unit dose cups; Lot: Lot 3H43, Exp. 02/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications : Out-of-specification result for an unidentified impurity at the 12 month stability test point.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pharmaceutical Associates Inc
Distributor
Nationwide
Lot
Lot 3H43, Exp. 02/15
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cyproheptadine HCl Syrup (Cyproheptadine HCl Oral Solution, USP) 4mg/10 mL, Rx ONLY, Pharmaceutical Associates, Inc., Greenville, SC 29605, NDC 0121-4788-10 recalled?

Yes. FDA published recall D-0240-2015 on November 12, 2014. Reported hazard: Failed Impurities/Degradation Specifications : Out-of-specification result for an unidentified impurity at the 12 month stability test point.

What should I do if I have this product?

Voluntary: Firm initiated · Letter